104 related articles for article (PubMed ID: 23442161)
1. Through the looking glass: adventures in kinase inhibitor design and optimization.
Clark RD
J Med Chem; 2013 Mar; 56(5):1796-8. PubMed ID: 23442161
[TBL] [Abstract][Full Text] [Related]
2. Design and optimization of selective protein kinase C θ (PKCθ) inhibitors for the treatment of autoimmune diseases.
Jimenez JM; Boyall D; Brenchley G; Collier PN; Davis CJ; Fraysse D; Keily SB; Henderson J; Miller A; Pierard F; Settimo L; Twin HC; Bolton CM; Curnock AP; Chiu P; Tanner AJ; Young S
J Med Chem; 2013 Mar; 56(5):1799-810. PubMed ID: 23398373
[TBL] [Abstract][Full Text] [Related]
3. Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors.
Cole DC; Asselin M; Brennan A; Czerwinski R; Ellingboe JW; Fitz L; Greco R; Huang X; Joseph-McCarthy D; Kelly MF; Kirisits M; Lee J; Li Y; Morgan P; Stock JR; Tsao DH; Wissner A; Yang X; Chaudhary D
J Med Chem; 2008 Oct; 51(19):5958-63. PubMed ID: 18783200
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and PKCtheta inhibitory activity of a series of 5-vinyl phenyl sulfonamide-3-pyridinecarbonitriles.
Shim J; Eid C; Lee J; Liu E; Chaudhary D; Boschelli DH
Bioorg Med Chem Lett; 2009 Dec; 19(23):6575-7. PubMed ID: 19854645
[TBL] [Abstract][Full Text] [Related]
5. First generation 5-vinyl-3-pyridinecarbonitrile PKCtheta inhibitors.
Niu C; Boschelli DH; Tumey LN; Bhagirath N; Subrath J; Shim J; Wang Y; Wu B; Eid C; Lee J; Yang X; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 Oct; 19(20):5829-32. PubMed ID: 19762237
[TBL] [Abstract][Full Text] [Related]
6. Practical application of 3-substituted-2,6-difluoropyridines in drug discovery: Facile synthesis of novel protein kinase C theta inhibitors.
Katoh T; Tomata Y; Setoh M; Sasaki S; Takai T; Yoshitomi Y; Yukawa T; Nakagawa H; Fukumoto S; Tsukamoto T; Nakada Y
Bioorg Med Chem Lett; 2017 Jun; 27(11):2497-2501. PubMed ID: 28400232
[TBL] [Abstract][Full Text] [Related]
7. 5-Vinyl-3-pyridinecarbonitrile inhibitors of PKCtheta: optimization of enzymatic and functional activity.
Tumey LN; Bhagirath N; Brennan A; Brooijmans N; Lee J; Yang X; Boschelli DH
Bioorg Med Chem; 2009 Dec; 17(23):7933-48. PubMed ID: 19884013
[TBL] [Abstract][Full Text] [Related]
8. Optimization of 5-phenyl-3-pyridinecarbonitriles as PKCtheta inhibitors.
Boschelli DH; Wang D; Prashad AS; Subrath J; Wu B; Niu C; Lee J; Yang X; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 Jul; 19(13):3623-6. PubMed ID: 19447612
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles.
Dushin RG; Nittoli T; Ingalls C; Boschelli DH; Cole DC; Wissner A; Lee J; Yang X; Morgan P; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 May; 19(9):2461-3. PubMed ID: 19345579
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and PKCtheta inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitriles.
Boschelli DH; Wu B; Barrios Sosa AC; Chen J; Asselin M; Cole DC; Lee J; Yang X; Chaudhary D
Bioorg Med Chem Lett; 2008 May; 18(9):2850-3. PubMed ID: 18434148
[TBL] [Abstract][Full Text] [Related]
11. C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCtheta inhibitors: part II.
Prashad AS; Wang D; Subrath J; Wu B; Lin M; Zhang MY; Kagan N; Lee J; Yang X; Brennan A; Chaudhary D; Xu X; Leung L; Wang J; Boschelli DH
Bioorg Med Chem Lett; 2009 Oct; 19(19):5799-802. PubMed ID: 19703774
[TBL] [Abstract][Full Text] [Related]
12. Optimization of 2,4-diamino-5-fluoropyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions and P-gp liability.
Kunikawa S; Tanaka A; Mukoyoshi K; Nagashima S; Tominaga H; Chida N; Tasaki M; Shirai F
Bioorg Med Chem; 2015 Jul; 23(13):3269-77. PubMed ID: 25982074
[TBL] [Abstract][Full Text] [Related]
13. Structure-based optimization of PKCtheta inhibitors.
Mosyak L; Xu Z; Joseph-McCarthy D; Brooijmans N; Somers W; Chaudhary D
Biochem Soc Trans; 2007 Nov; 35(Pt 5):1027-31. PubMed ID: 17956269
[TBL] [Abstract][Full Text] [Related]
14. Selective protein kinase Cθ (PKCθ) inhibitors for the treatment of autoimmune diseases.
Curnock A; Bolton C; Chiu P; Doyle E; Fraysse D; Hesse M; Jones J; Weber P; Jimenez JM
Biochem Soc Trans; 2014 Dec; 42(6):1524-8. PubMed ID: 25399564
[TBL] [Abstract][Full Text] [Related]
15. 2-Alkenylthieno[2,3-b]pyridine-5-carbonitriles: Potent and selective inhibitors of PKCtheta.
Nathan Tumey L; Boschelli DH; Lee J; Chaudhary D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4420-3. PubMed ID: 18606543
[TBL] [Abstract][Full Text] [Related]
16. Small molecule inhibitors of PKCTheta as potential antiinflammatory therapeutics.
Boschelli DH
Curr Top Med Chem; 2009; 9(7):640-54. PubMed ID: 19689371
[TBL] [Abstract][Full Text] [Related]
17. Directed modulation of protein kinase C isozyme selectivity with bisubstrate-based inhibitors.
van Wandelen LT; van Ameijde J; Mady AS; Wammes AE; Bode A; Poot AJ; Ruijtenbeek R; Liskamp RM
ChemMedChem; 2012 Dec; 7(12):2113-21. PubMed ID: 23139239
[TBL] [Abstract][Full Text] [Related]
18. 2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.
van Eis MJ; Evenou JP; Floersheim P; Gaul C; Cowan-Jacob SW; Monovich L; Rummel G; Schuler W; Stark W; Strauss A; von Matt A; Vangrevelinghe E; Wagner J; Soldermann N
Bioorg Med Chem Lett; 2011 Dec; 21(24):7367-72. PubMed ID: 22078216
[TBL] [Abstract][Full Text] [Related]
19. Development of selective bisubstrate-based inhibitors against protein kinase C (PKC) isozymes by using dynamic peptide microarrays.
Poot AJ; van Ameijde J; Slijper M; van den Berg A; Hilhorst R; Ruijtenbeek R; Rijkers DT; Liskamp RM
Chembiochem; 2009 Aug; 10(12):2042-51. PubMed ID: 19618415
[TBL] [Abstract][Full Text] [Related]
20. Discovery of selective and orally bioavailable protein kinase Cθ (PKCθ) inhibitors from a fragment hit.
George DM; Breinlinger EC; Friedman M; Zhang Y; Wang J; Argiriadi M; Bansal-Pakala P; Barth M; Duignan DB; Honore P; Lang Q; Mittelstadt S; Potin D; Rundell L; Edmunds JJ
J Med Chem; 2015 Jan; 58(1):222-36. PubMed ID: 25000588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
